<Li> Jump up ^ Ioannidis JP, Lau J (2001). "Completeness of safety reporting in randomized trials: an evaluation of 7 medical areas". JAMA. 285 (4): 437--43 . doi: 10.1001 / jama. 285.4. 437 . PMID 11242428 . </Li> <Li> Jump up ^ Chou R, Helfand M (2005). "Challenges in systematic reviews that assess treatment harms". Ann Intern Med. 142 (12 Pt 2): 1090--0 . doi: 10.7326 / 0003 - 4819 - 142 - 12_part_2 - 200506211 - 00009 . PMID 15968034 . </Li> <Li> Jump up ^ Ioannidis JP, Evans SJ, Gøtzsche PC, O'Neill RT, Altman DG, Schulz K, Moher D, CONSORT Group (2004). "Better reporting of harms in randomized trials: an extension of the CONSORT statement". Ann Intern Med. 141 (10): 781--8 . doi: 10.7326 / 0003 - 4819 - 141 - 10 - 200411160 - 00009 . PMID 15545678 . </Li>

Difference between serious adverse event and severe adverse event